These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16091938)
1. A new technique for the quantitative assessment of 8-oxoguanine in nuclear DNA as a marker of oxidative stress. Application to dystrophin-deficient DMD skeletal muscles. Nakae Y; Stoward PJ; Bespalov IA; Melamede RJ; Wallace SS Histochem Cell Biol; 2005 Sep; 124(3-4):335-45. PubMed ID: 16091938 [TBL] [Abstract][Full Text] [Related]
2. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice. Nakae Y; Stoward PJ; Kashiyama T; Shono M; Akagi A; Matsuzaki T; Nonaka I J Mol Histol; 2004 Jun; 35(5):489-99. PubMed ID: 15571326 [TBL] [Abstract][Full Text] [Related]
3. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles? Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920 [TBL] [Abstract][Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
5. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies. Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784 [TBL] [Abstract][Full Text] [Related]
6. The involvement of oxidative stress in determining the severity and progress of pathological processes in dystrophin-deficient muscles. Niebrój-Dobosz I; Hausmanowa-Petrusewicz I Acta Biochim Pol; 2005; 52(2):449-52. PubMed ID: 15990924 [TBL] [Abstract][Full Text] [Related]
7. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle. Yuasa K; Nakamura A; Hijikata T; Takeda S BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway. Petrillo S; Pelosi L; Piemonte F; Travaglini L; Forcina L; Catteruccia M; Petrini S; Verardo M; D'Amico A; Musarò A; Bertini E Hum Mol Genet; 2017 Jul; 26(14):2781-2790. PubMed ID: 28472288 [TBL] [Abstract][Full Text] [Related]
9. Localized expression of specific P2X receptors in dystrophin-deficient DMD and mdx muscle. Jiang T; Yeung D; Lien CF; Górecki DC Neuromuscul Disord; 2005 Mar; 15(3):225-36. PubMed ID: 15725584 [TBL] [Abstract][Full Text] [Related]
12. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases. Jong YJ; Chuang YH; Chen SS; Chen BH; Chiang CH J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882 [TBL] [Abstract][Full Text] [Related]
19. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069 [TBL] [Abstract][Full Text] [Related]
20. The role of branched fibres in the pathogenesis of Duchenne muscular dystrophy. Chan S; Head SI Exp Physiol; 2011 Jun; 96(6):564-71. PubMed ID: 21421700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]